Skip to main content
Year archive

CYCLOPHARM LIMITED — 2023 filings

All 39 regulatory filings released by CYCLOPHARM LIMITED (CYC) in 2023, sourced directly from the official regulator.

39 Filings
2023 Period
2023 filings (39)
Filing Released Lang
Cyclopharm Signs First USA Contract for Technegas 2 pages 139.7KB
Capital/Financing Update
2023-12-04 English
Application for quotation of securities - CYC 6 pages 27.8KB
Share Issue/Capital Change
2023-11-30 English
Change of Director's Interest Notice 2 pages 204.6KB
Director's Dealing
2023-11-30 English
Technegas USA Commercialisation Update 3 pages 159.3KB
Capital/Financing Update
2023-11-14 English
Change of Director's Interest Notice 2 pages 225.6KB
Director's Dealing
2023-11-01 English
Change of Director's Interest Notice 2 pages 224.4KB
Director's Dealing
2023-10-31 English
CYC USFDA Approval Webinar Presentation 22 pages 2.9MB
Investor Presentation
2023-10-04 English
SNMMI Announcement Regarding USFDA Approval of Technegas 2 pages 183.9KB
Regulatory Filings
2023-10-02 English
FDA Technegas Approval Webinar 2 pages 129.1KB
Regulatory Filings
2023-10-02 English
Cyclopharm Receives USFDA Approval for Technegas 4 pages 185.0KB
Regulatory Filings
2023-10-01 English
Cyclopharm Investor Update 21 pages 3.3MB
Investor Presentation
2023-09-25 English
Investor Presentation Correction 22 pages 3.4MB
Investor Presentation
2023-09-25 English
Investor Presentation Correction 1 page 154.5KB
Investor Presentation
2023-09-25 English
Application for quotation of securities - CYC 7 pages 29.5KB
Share Issue/Capital Change
2023-09-11 English
Litigation Update and Receipt of Settlement Payment 1
Legal Proceedings Report
2023-08-24 English
Half Year Accounts 31 pages 732.6KB
Interim / Quarterly Report
2023-08-21 English
Dividend/Distribution - CYC 4 pages 24.5KB
Notice of Dividend Amount
2023-08-21 English
USFDA Approval Process Update 2 pages 185.6KB
Regulatory Filings
2023-08-08 English
Cyclopharm 2023 Half Year Accounts Update - Record Revenues 3 pages 159.5KB
Capital/Financing Update
2023-07-16 English
Chairman's Address to Shareholders 4 pages 154.9KB
AGM Information
2023-05-15 English
CYC 2023 AGM Presentation 31 pages 2.4MB
AGM Information
2023-05-15 English
Managing Director's Address to Shareholders 8 pages 264.9KB
Investor Presentation
2023-05-15 English
Results of Meeting 2 pages 140.1KB
Declaration of Voting Results & Voting Rights Announcements
2023-05-15 English
Notification of buy-back - CYC 5 pages 24.6KB
Transaction in Own Shares
2023-05-15 English
Cyclopharm Confirms USFDA Scheduled Inspection Date 2 pages 185.2KB
Regulatory Filings
2023-05-08 English
USFDA Confirms Technegas Six Month Review Period 2 pages 183.1KB
Regulatory Filings
2023-04-23 English
Cyclopharm Acquires DuPharma ApS 2 pages 164.5KB
M&A Activity
2023-04-19 English
Application for quotation of securities - CYC 6 pages 27.7KB
Share Issue/Capital Change
2023-04-17 English
Proposed issue of securities - CYC 5 pages 28.2KB
Capital/Financing Update
2023-04-16 English
Notice of Annual General Meeting/Proxy Form 23 pages 1.3MB
AGM Information
2023-04-12 English
Cyclopharm USFDA Approval Progress Update 28 pages 3.8MB
Investor Presentation
2023-04-04 English
Annual Report to shareholders 88 pages 5.1MB
Annual Report
2023-03-30 English
Appendix 4G 22 pages 427.1KB
Regulatory Filings
2023-03-30 English
Technegas Enters Final Six Month USFDA Review Cycle 4 pages 207.9KB
Capital/Financing Update
2023-03-29 English
Application for quotation of securities - CYC 7 pages 29.4KB
Capital/Financing Update
2023-03-23 English
Date of Annual General Meeting 1 page 77.7KB
AGM Information
2023-03-14 English
Dividend/Distribution - CYC 4 pages 25.0KB
Notice of Dividend Amount
2023-02-19 English
Preliminary Final Report 70 pages 556.7KB
Annual Report
2023-02-19 English
CYC Results Summary 4 pages 166.9KB
Annual Report
2023-02-19 English